Prenatal Exposure to Zika Virus and Risk of Epilepsy-Related Hospitalization During Early Childhood

João Guilherme G Tedde1,2, Thiago Cerqueira-Silva3,4, Orlagh Carroll3

  • 1Center for Data and Knowledge Integration for Health, Oswaldo Cruz Foundation, Salvador, Brazil.

JAMA Pediatrics
|December 1, 2025
PubMed

Insights

Congenital Zika syndrome (CZS) significantly increases epilepsy risk in children. However, Zika virus (ZIKV) exposure during pregnancy without CZS did not elevate epilepsy hospitalization rates in this Brazilian study.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Epidemiology

Background:

  • Epilepsy is a significant concern in children with congenital Zika syndrome (CZS).
  • The epilepsy risk for children exposed in utero to Zika virus (ZIKV) without developing CZS remains unclear compared to unexposed children.

Purpose of the Study:

  • To compare the risk of epilepsy-related hospitalizations in the first four years of life.
  • To assess risk among children exposed to ZIKV in utero (with and without CZS) versus unexposed children.

Main Methods:

  • Population-based cohort study in Brazil (January 2015 - November 2018).
  • Included live-born singleton children with 22+ weeks gestation.
  • Analyzed epilepsy-related hospitalizations using Cox regression, adjusting for confounders.

Main Results:

  • CZS was strongly associated with increased epilepsy hospitalization risk (aHR, 34.22).
  • Risk peaked between 7-18 months of age.
  • ZIKV exposure without CZS showed no increased epilepsy risk compared to unexposed children (aHR, 0.66).

Conclusions:

  • CZS is linked to a substantially elevated risk of epilepsy-related hospitalizations in early childhood.
  • In utero ZIKV exposure without CZS does not appear to increase epilepsy risk.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
586